Stock-based Compensation (Tables)
|
9 Months Ended |
Dec. 31, 2025 |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of stock-based compensation expense [Table Text Block] |
| |
|
Three months ended December 31, |
|
|
Nine months ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Stock options |
$ |
22 |
|
$ |
52 |
|
$ |
86 |
|
$ |
226 |
|
| RSUs |
|
6,976 |
|
|
3,474 |
|
|
18,134 |
|
|
6,023 |
|
| Total |
$ |
6,998 |
|
$ |
3,526 |
|
$ |
18,220 |
|
$ |
6,249 |
|
|
| Schedule of changes in restricted share units outstanding [Table Text Block] |
| |
|
Outstanding |
|
| |
|
|
|
| Balance, March 31, 2024 |
|
1,379,056 |
|
| Granted |
|
6,050,000 |
|
| Exercised |
|
(326,644 |
) |
| Balance, March 31, 2025 |
|
7,102,412 |
|
| Granted |
|
8,326,900 |
|
| Exercised |
|
(1,846,882 |
) |
| Balance, December 31, 2025 |
|
13,582,430 |
|
|
| CAD exercise price [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of changes in stock options outstanding [Table Text Block] |
| |
|
Outstanding |
|
|
Weighted average
exercise price - CAD
|
|
| Balance, March 31, 2024 |
|
3,465,915 |
|
$ |
5.24 |
|
| Change in exercise price |
|
(1,605,015 |
) |
|
(3.32 |
) |
| Balance, March 31, 2025 |
|
1,860,900 |
|
$ |
6.89 |
|
| Exercised |
|
(75,100 |
) |
|
(5.98 |
) |
| Balance, December 31, 2025 |
|
1,785,800 |
|
$ |
6.93 |
|
|
| Schedule of stock options outstanding and exercisable [Table Text Block] |
| |
Outstanding |
|
|
Exercisable |
|
|
Exercise price - CAD |
|
|
Expiry date |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
2,000 |
|
|
2,000 |
|
$ |
15.70 |
|
|
February 11. 2026 |
|
| |
282,400 |
|
|
282,400 |
|
|
5.66 |
|
|
August 26, 2027 |
|
| |
50,000 |
|
|
50,000 |
|
|
10.00 |
|
|
March 26, 2028 |
|
| |
470,000 |
|
|
470,000 |
|
|
6.86 |
|
|
July 6, 2028 |
|
| |
400,000 |
|
|
400,000 |
|
|
3.10 |
|
|
September 18, 2028 |
|
| |
100,000 |
|
|
100,000 |
|
|
1.35 |
|
|
December 21, 2028 |
|
| |
200,000 |
|
|
200,000 |
|
|
1.45 |
|
|
February 10, 2030 |
|
| |
20,000 |
|
|
20,000 |
|
|
1.90 |
|
|
May 29, 2030 |
|
| |
1,400 |
|
|
1,400 |
|
|
10.80 |
|
|
December 24, 2030 |
|
| |
60,000 |
|
|
60,000 |
|
|
18.35 |
|
|
April 29, 2031 |
|
| |
180,000 |
|
|
153,000 |
|
|
18.50 |
|
|
October 7, 2031 |
|
| |
40,000 |
|
|
40,000 |
|
|
25.35 |
|
|
November 10, 2031 |
|
| |
1,785,800 |
|
|
1,758,800 |
|
|
|
|
|
|
|
|
| USD exercise price [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of changes in stock options outstanding [Table Text Block] |
| |
|
Outstanding |
|
|
Weighted average
exercise price - USD
|
|
| Balance, March 31, 2024 |
|
- |
|
$ |
- |
|
| Change in exercise price |
|
1,605,015 |
|
|
2.62 |
|
| Expired |
|
(54,615 |
) |
|
(7.75 |
) |
| Exercised |
|
(100,000 |
) |
|
(1.09 |
) |
| Balance, March 31, 2025 |
|
1,450,400 |
|
$ |
2.53 |
|
| Exercised |
|
(600,000 |
) |
|
(1.21 |
) |
| Balance, December 31, 2025 |
|
850,400 |
|
$ |
3.47 |
|
|
| Schedule of stock options outstanding and exercisable [Table Text Block] |
| |
Outstanding |
|
|
Exercisable |
|
|
Exercise price - USD |
|
|
Expiry date |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
50,400 |
|
|
50,400 |
|
$ |
4.36 |
|
|
August 26, 2027 |
|
| |
500,000 |
|
|
500,000 |
|
|
1.23 |
|
|
September 14, 2027 |
|
| |
130,000 |
|
|
130,000 |
|
|
5.14 |
|
|
July 6, 2028 |
|
| |
100,000 |
|
|
100,000 |
|
|
1.09 |
|
|
February 10, 2030 |
|
| |
30,000 |
|
|
30,000 |
|
|
20.03 |
|
|
April 6, 2031 |
|
| |
20,000 |
|
|
- |
|
|
20.36 |
|
|
November 10, 2031 |
|
| |
20,000 |
|
|
20,000 |
|
|
16.61 |
|
|
December 9, 2031 |
|
| |
850,400 |
|
|
830,400 |
|
|
|
|
|
|
|
|